Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …

In the long-term, with progression of the illness, Parkinson's disease dementia affects up to
90% of patients with Parkinson's disease. With increasing life expectancy in western …

People with Parkinson's disease (PD) and their care partners frequently report cognitive
decline as one of their greatest concerns. Mild cognitive impairment affects approximately 20 …

The purpose of this work was to evaluate changes in the connectivity patterns of a set of
cognitively relevant, dynamically interrelated brain networks in association with cognitive …

Mild cognitive impairment (PD-MCI) and dementia (PDD) are among the most frequent non-
motor symptoms in Parkinson's disease (PD). PD-MCI is six times more likely than age …

Cognitive decline is one of the most frequent and disabling nonmotor features of Parkinson's
disease. Around 30% of patients with Parkinson's disease experience mild cognitive …

Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease
(PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia …

One of the most fundamental features of the human brain is its ability to detect and attend to
salient goal-relevant events in a flexible manner. The salience network (SN), anchored in …

Patients with Parkinson's disease experience a range of non-motor symptoms, including
cognitive impairment, behavioural changes, somatosensory and autonomic disturbances …

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian
disorders. One current challenge is to identify biomarkers of early changes that may predict …